← Back to Search

Novel Wearable Device for Hypoxia

N/A
Recruiting
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Suspected to suffer from hypoxic events
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15-20 minutes depending on the patients questions.
Awards & highlights

Study Summary

This trial will test how well a new device prototype works in measuring oxygen and movement.

Who is the study for?
This trial is for adults over 21 who can give informed consent and are suspected to experience low oxygen levels (hypoxia). Pregnant individuals cannot participate.Check my eligibility
What is being tested?
The study is testing the functionality of a new wearable device's components: an FDA approved pulse oximeter, which measures oxygen levels in blood, and an accelerometer that tracks movement.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring with a wearable device, significant side effects are not expected. However, minor skin irritation or discomfort from wearing the device may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I might have had episodes where my body didn't get enough oxygen.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15-20 minutes depending on the patients questions.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15-20 minutes depending on the patients questions. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparing Dove device against FDA approved SpO2 sensor
Secondary outcome measures
Questionnaire about comfort of device

Trial Design

1Treatment groups
Experimental Treatment
Group I: Assess device prototype functionalityExperimental Treatment1 Intervention
Everyone will be in the same arm

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,840 Total Patients Enrolled
3 Trials studying Hypoxia
155 Patients Enrolled for Hypoxia

Media Library

Assess device prototype functionality Clinical Trial Eligibility Overview. Trial Name: NCT05197790 — N/A
Hypoxia Research Study Groups: Assess device prototype functionality
Hypoxia Clinical Trial 2023: Assess device prototype functionality Highlights & Side Effects. Trial Name: NCT05197790 — N/A
Assess device prototype functionality 2023 Treatment Timeline for Medical Study. Trial Name: NCT05197790 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to participate in this clinical trial?

"Indeed, the data on clinicaltrials.gov shows that this medical experiment is actively seeking participants; it was initially listed on May 20th 2022 and most recently updated September 29th 2022. Currently, 40 individuals are needed to participate at 1 location."

Answered by AI

What is the magnitude of recruitment for this clinical trial?

"Affirmative. The details hosted on clinicaltrials.gov confirm that this medical trial, which was initially posted in May 2022, is actively searching for suitable patients to enroll. 40 people need to be recruited from 1 centre for the study's completion."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
~14 spots leftby Apr 2025